FDA Approved: AMBRISENTAN — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for Ambrisentan submitted by Apotex Corp., marking an additional regulatory action for this medication. Ambrisentan is u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Ambrisentan (Ambrisentan)

Snippet

SUPPL AP for AMBRISENTAN (AMBRISENTAN)